Mid-term evaluation of the new Glaukos iStent with phacoemulsification in coexistent open-angle glaucoma or ocular hypertension and cataract

British Journal of Ophthalmology

Volumn 97, Issue 10, 2013, Pages 1250-1255

  Arriola Villalobos, Pedro ^a   Martínez de la Casa, José Maria ^a,b   Díaz Valle, David ^a,b   García Vidal, Sara E ^a   Fernández Pérez, Cristina ^a   García Sánchez, Julián ^a,b,c   García Feijoó, Julián ^a,b,c  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT;

ADULT; AGED; ARGON LASER; ARTICLE; CATARACT; CELL COUNT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL; DEVICE SAFETY; DRUG USE; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTERVENTION STUDY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE ABNORMALITY; LOW LEVEL LASER THERAPY; MALE; MEDICAL DEVICE COMPLICATION; OPEN ANGLE GLAUCOMA; OPHTHALMOLOGICAL IMPLANT; OUTCOME ASSESSMENT; PHACOEMULSIFICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOEXFOLIATIVE GLAUCOMA; STENT; STENT OCCLUSION; TRABECULAR MICROBYPASS STENT; VISUAL ACUITY;

AQUEOUS HUMOUR; GLAUCOMA; TREATMENT SURGERY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CATARACT; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PHACOEMULSIFICATION; PROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 84884675029     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-302394     Document Type: Article

References (21)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-7.
2. Leske MC, Heijl A, Hyman L, et al. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Curr Opin Ophthalmol 2004;15:102-6.
3. Baudouin C, Pisella PJ, Fillacier K, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 1999;106:556-63.
4. Juzych MS, Chopra V, Banitt MR, et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology 2004;111:1853-9.
5. Jampel HD, Musch DC, Gillespie BW, et al. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 2005;140:16-22.
6. Ang GS, Varga Z, Shaarawy T. Postoperative infection in penetrating versus non-penetrating glaucoma surgery. Br J Ophthalmol 2010;94:1571-6.
7. Poley BJ, Lindstrom RL, Samuelson TW, et al. Intraocular pressure reduction after phacoemulsification with intraocular lens implantation in glaucomatous and nonglaucomatous eyes: evaluation of a causal relationship between the natural lens and open-angle glaucoma. J Cataract Refract Surg 2009;35:1946-55.
8. Shrivastava A, Singh K. The effect of cataract extraction on intraocular pressure. Curr Opin Ophthalmol 2010;21:118-22.
9. Bahler CK, Smedley GT, Zhou J, et al. Trabecular bypass stents decrease intraocular pressure in cultured human anterior segments. Am J Ophthalmol 2004;138:988-94.
10. Fernández-Barrientos Y, García-Feijoó J, Martínez-de-la-Casa JM, et al. Fluorophotometric study of the effect of the glaukos trabecular microbypass stent on aqueous humor dynamics. Invest Ophthalmol Vis Sci 2010;51: 3327-32.
11. Spiegel D, Wetzel W, Neuhann T, et al. Coexistent primary open-angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery. Eur J Ophthalmol 2009;19:393-9.
12. Fea AM. Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma: randomized double-masked clinical trial. J Cataract Refract Surg 2010;36:407-12.
13. Samuelson TW, Katz LJ, Wells JM, et al. Randomized Evaluation of the Trabecular Micro-Bypass Stent with Phacoemulsification in Patients with Glaucoma and Cataract. Ophthalmology 2011;118:459-67.
14. Arriola-Villalobos P, Martínez-de-la-Casa JM, Díaz-Valle D, et al. Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study. Br J Ophthalmol 2012;96:645-9.
15. Cheung SW, Cho P. Endothelial cells analysis with the TOPCON specular microscope SP-2000P and IMAGEnet system. Curr Eye Res 2000;21:788-98.
16. Hodapp E, Parrish RK, Anderson DR. Initial treatment of primary open-angle glaucoma. In: Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St. Louis: Mosby, 1993:52-9.
17. Singh K, Lee BL, Wilson MR, Glaucoma Modified RANDLike Methodology Group. A panel assessment of glaucoma management: modification of existing RAND-like methodology for consensus in ophthalmology. Part II: Results and interpretation. Am J Ophthalmol 2008;145:575-81.
18. Broadway DC, Grierson I, O'Brien C, et al. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 1994;112:1446-54.
19. Huang G, Gonzalez E, Peng PH, et al. Anterior chamber depth, iridocorneal angle width, and intraocular pressure changes after phacoemulsification: narrow vs open iridocorneal angles. Arch Ophthalmol 2011;129:1283-90.
20. Hau S, Barton K. Corneal complications of glaucoma surgery. Curr Opin Ophthalmol 2009;20:131-6.
21. Bourne RR, Minassian DC, Dart JK, et al. Effect of cataract surgery on the corneal endothelium: modern phacoemulsification compared with extracapsular cataract surgery. Ophthalmology 2004;111:679-85.